| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Of Business Development
1 company
Flowers Lee serves as a SVP Of Business Development at HCWB. Across recent SEC filings that breaks down to 7 buys and 0 sells. Those positions are worth an estimated $23K at current prices.
Historically, Flowers Lee's trades have earned a below-average insider score of 23/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -56.7%.
The biggest single holding is HCWB (~$23K) as SVP Of Business Development. Net of sales, the recent Form 4 record there shows accumulation of 73,938 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 7,736 | $2.59 | $19,997.56 | +810.1% | - | - | |
| May 8, 2025 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 962 | $26.00 | $25,012.00 | +20.2% | -36.8% | -95.4% | |
| Jun 8, 2023 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 10,000 | $2.16 | $21,574.00 | +9.9% | -12.1% | -51.6% | |
| Aug 23, 2021 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 13,458 | $4.03 | $54,225.86 | +8.2% | -30.9% | -43.0% | |
| Aug 19, 2021 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 10,532 | $4.25 | $44,785.22 | +15.6% | -31.0% | -51.5% | |
| Jul 22, 2021 | HCWB Hcw Biologics Inc. | SVP Of Business Development | Buy | 31,250 | $8.00 | $250,000.00 | +85.8% | -42.6% | -50.1% |